12
total announcements
MEDICO.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 20 Oct 2026
Market Cap
₹178 Cr
P/E (TTM)
12.8
EPS (TTM)
₹1.67
52W Low
₹20.47
52W High
₹56.88
Dividend Yield
0.00%
Beta
0.71
Price / Book
2.3
Debt / Equity
25.4
Revenue (TTM)
₹238 Cr
Gross Margin
24.33%
Operating Margin
3.71%
Medico Remedies Limited
Medico Remedies Limited has responded to a query from the Bombay Stock Exchange and the National Stock Exchange regarding a significant price movement in the company's shares. The company stated that there is no pending information or announcement required to be disclosed, and that the price movement is purely due to market conditions.
Medico Remedies Limited
Medico Remedies Limited has experienced significant price movement, prompting the NSE to seek clarification from the company.
Medico Remedies Limited
Medico Remedies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
Medico Remedies Limited
Medico Remedies Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 22, 2026, and informed the Exchange regarding voting results.
Medico Remedies Limited
Medico Remedies Limited has held its 32nd Annual General Meeting on September 22, 2026, through video conferencing, where the company's financial statements for FY 2026 were adopted, and several resolutions were passed, including the re-appointment of directors and increases in remuneration.
Medico Remedies Limited
Medico Remedies Limited has informed the Exchange about Book Closure Dates for its 32nd Annual General Meeting scheduled on September 22, 2026.
Medico Remedies Limited
Medico Remedies Limited has informed the Exchange regarding Notice of 32nd Annual General Meeting to be held on September 22, 2026.
Medico Remedies Limited
Medico Remedies Limited has announced its quarterly standalone financial results for the quarter ended June 30, 2026, along with the re-appointment of two directors, Mr. Rishit Mehta and Mr. Haresh Mehta, and an increase in remuneration for the Managing Director, Mr. Harshit Mehta.
Medico Remedies Limited
Medico Remedies Limited has secured a government supply order worth USD 1.40645 million from PROMESE/CAL, Dominican Republic, to supply tablets, capsules, and dry syrups. The order is expected to be completed within 3 months.
Medico Remedies Limited
Medico Remedies Limited has experienced significant price movement, prompting the exchange to request information from the company to ensure transparency and protect investor interests.
Medico Remedies Limited
Medico Remedies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window is closed for all insiders, designated persons, and their immediate relatives from July 1, 2026, up to 48 hours post the declaration of unaudited financial results for the quarter ended June 30, 2026.
Medico Remedies Limited
Medico Remedies Limited has informed the Exchange about the reaffirmation of its credit ratings by CRISIL Ratings Limited for its long-term and short-term bank facilities.